GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)
Condition: Moderate Alzheimer's Disease Interventions: Drug: GV1001; Drug: Normal saline Sponsor: GemVax & Kael Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alzheimer's | Research